Evaluation of mucosal healing in ulcerative colitis by fecal calprotectin vs. fecal immunochemical test

American Journal of Gastroenterology

Volumn 110, Issue 6, 2015, Pages 873-880

  Takashima, Shiho ^a   Kato, Jun ^b   Hiraoka, Sakiko ^a   Nakarai, Asuka ^a   Takei, Daisuke ^a   Inokuchi, Toshihiro ^a   Sugihara, Yuusaku ^a   Takahara, Masahiro ^a   Harada, Keita ^a   Okada, Hiroyuki ^a   Tanaka, Takehiro ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; BIOLOGICAL MARKER; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; COLONOSCOPY; FECAL CALPROTECTIN TEST; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HEALING; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MAYO ENDOSCOPIC SUBSCORE; MUCOSA; MUCOSAL HEALING; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; CHEMISTRY; COMPARATIVE STUDY; FECES; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; OCCULT BLOOD; PATHOLOGY; PROSPECTIVE STUDY; WOUND HEALING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COLONOSCOPY; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; INTESTINAL MUCOSA; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; WOUND HEALING; YOUNG ADULT;

EID: 84930763874     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.66     Document Type: Article

References (25)

1. Peyrin-Biroulet L, Ferrante M, Magro F et al. Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5: 477-83.
2. Lez-Palacios N, Mendoza JL, Taxonera C et al. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy. Eur J Intern Med 2011;22: 621-5.
3. Chen LS, Yen AM, Chiu SY et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011;12: 551-8.
4. Daperno M, Castiglione F, de Ridder L et al. Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. J Crohns Colitis 2011;5: 484-98.
5. D'Haens G, Ferrante M, Vermeire S et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012;18: 2218-24.
6. Schoepfer AM, Beglinger C, Straumann A et al. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis 2009;15: 1851-8.
7. Schoepfer AM, Beglinger C, Straumann A et al. Fecal calprotectin more accurately refl ects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes. Inflamm Bowel Dis 2013;19: 332-41.
8. Lobat T, Rodruez-Moranta F, Lopez A et al. A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis. Inflamm Bowel Dis 2013;19: 1034-42.
9. Nancey S, Boschetti G, Moussata D et al. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2013;19: 1043-52.
10. D'Inc R, Dal Pont E, Di Leo V et al. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis 2007;22: 429-37.
11. Nal K, Beyazit Y, Ener B et al. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis. Turk J Gastroenterol 2012;23: 509-14.
12. Nakarai A, Kato J, Hiraoka S et al. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test. Am J Gastroenterol 2013;108: 83-9.
13. Vilkin A, Rozen P, Levi Z et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 2005;100: 2519-25.
14. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317: 1625-9.
15. Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011;141: 1194-201.
16. Kuriyama M, Kato J, Takemoto K et al. Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test. World J Gastroenterol 2010;16: 1110-4.
17. Geboes K, Riddell R, Ost A et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000;47: 404-9.
18. Mooiweer E, Fidder HH, Siersema PD et al. Fecal hemoglobin and calprotectin are equally Effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation. Inflamm Bowel Dis 2014;20: 307-14.
19. Paul S, Del Tedesco E, Marotte H et al. Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study. Inflamm Bowel Dis 2013;19: 2568-76.
20. Meucci G, Fasoli R, Saibeni S et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study. Inflamm Bowel Dis 2012;18: 1006-10.
21. Laharie D, Filippi J, Roblin X et al. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience. Aliment Pharmacol Ther 2013;37: 998-1004.
22. Nakarai A, Kato J, Hiraoka S et al. Prognosis of ulcerative colitis diff ers between patients with complete and partial mucosal healing, which can be predicted from the platelet count. World J Gastroenterol 20: 18367-74.
23. Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010;16: 338-46.
24. Van Turenhout ST, Oort FA, Terhaarsive Droste JS et al. Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results. Gastrointest Endosc. 2012;76: 136-43.
25. Nakama H, Kamijo N, Fujimori K et al. Immunochemical fecal occult blood test is not suitable for diagnosis of hemorrhoids. Am J Med 1997;102: 551-4.